ICU Webinar

Organized by the EACTA Educational Committee in collaboration with the Intensive Care Unit Committee
The Can we avoid ECMO in the management of post cardiotomy shock?, 04/11/2019-04/11/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

A certificate of attendance will be issued after the course and sent by e-mail


Specializations of the target audience: Anaesthesiology, Intensive Care, Perfusion, Cardiac Surgery, Cardiac anaesthesia, Vascular Anaesthesia, Nurses, Medical Students and Interns

Chair of the Webinar:

Dr. Philippe Gaudard, France, Chair of EACTA ICU Subspecialty Committee.

Scientific Moderators:

  • Dr. Peter Rosseel, Belgium, EACTA ICU Committee.  
  • Dr. Daniela Pasero, Italy, EACTA ICU and VAD and Transplant Committees.
  • Prof. Alexandre Ouattara, France, Chair of CAPSO congress.

Scientific Programme:

Welcome & Introduction Dr. Philippe Gaudard, Montpellier, France
Dr. Peter Rosseel, Belgium
Presentation (1): The use of ECMO for post-cardiotomy cardiogenic shock: New merits
Moderator: Dr. Daniela Pasero, Italy
Speaker: Dr. Antonio Rubino, United Kingdom
Presentation (2): The use of IABP or inotropes for post-cardiotomy cardiogenic shock
Moderator: Dr. Peter Rosseel, Belgium
Speaker: Dr. Isabelle Michaux, Belgium
Presentation (3): The use of temporary VAD for post-cardiotomy cardiogenic shock
Moderator: Dr. Daniela Pasero, Italy
Speaker: Professor Alexandre Ouattara, France
Presentation (4): Routine use of TEE to guide the mechanical circulatory support for cardiogenic shock
Moderator: Professor Alexandre Ouattara, France
Speaker: Dr. Priya Menon, Germany
Lessons from intensive care of patients with post-cardiotomy cardiogenic shock Dr. Philippe Gaudard, Montpellier, France
Take Home Message Dr. Peter Rosseel, Belgium
Conclusions Dr. Philippe Gaudard, Montpellier, France
Prof. Fabio Guarracino, President of EACTA

Take-Home Message

  • VA-ECMO for refractory PCCS needs to be started early when inotropes don’t work and needs to be customized to patient and surgical situation, including a combination with IABP
  • LV unloading is mandatory and minimal pulmonary flow needs to be preserved as much as possible
  • Anticipation or prevention is a key point for the use of IABP and probably Levosimendan in selected cases
  • Selective LV support or combined VAD are promising options
  • TEE is absolutely essential for the indication, the setting up, the follow up and the weaning of MCS


Technical information:

  • The speakers and attendees will be remote from each other.
  • The speakers, attendees, and moderator will use their own high-speed internet access, HD webcam, personal computer and HD microphone and headset. Any webcam that is recognized by your computer can be used in the system. We recommend higher quality webcams with 2+ Megapixels quality.
  • A dedicated, wired internet connection of at least 5 Mbps download/upload speed is required to present content using The Webinato, the USA, the technical solution for the webinar. Click here to check your connection
  • The IT technician from the Webinato will run and interact through connecting people (speakers, moderators, and attendees) together, mute non-talking persons, collect and pass questions to the scientific moderators.
  • Chat and Q & A: Interactive live webinar where the speakers will address the received questions from the attendees within the allocated time limits. The questions would be sent by the delegates to the Chat box 1, on the lower left corner, assigned for delegates for sending questions and by the IT support from Webinato to publish any announcements. That chat box could be read by all delegates and presenters.
  • If you need a support, please don't hesitate to check the Support Website


With an unrestricted grant by

This website uses cookies technical and third party cookie profiling cookies. To learn more, please click here. By closing this banner, continuing to browse, clicking or scrolling anywhere on the screen you will be giving your consent to use of all cookies.